Literature DB >> 3774722

Amiodarone and thyroid hormone metabolism.

W M Wiersinga, M D Trip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3774722      PMCID： PMC2419049          DOI： 10.1136/pgmj.62.732.909

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  31 in total

1.  [Research on the benzofuran series. XXXVII. Comparative study of transit and metabolism of amiodarone in different species of animals and humans].

Authors:  J Broekhuysen; R Laruel; R Sion
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-02

2.  Prednisone in amiodarone-induced thyrotoxicosis.

Authors:  C Wimpfheimer; M Stäubli; J Schädelin; H Studer
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

3.  The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

4.  Thyroid function tests. II. Studies in patients with thyroid diseases.

Authors:  W M Wiersinga; J L Touber
Journal:  Neth J Med       Date:  1980       Impact factor: 1.422

5.  Evidence for two tissue-specific pathways for in vivo thyroxine 5'-deiodination in the rat.

Authors:  J E Silva; J L Leonard; F R Crantz; P R Larsen
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

6.  Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.

Authors:  K Nademanee; B N Singh; J A Hendrickson; A W Reed; S Melmed; J Hershman
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

7.  Decreased transport of thyroxine (T4), 3,3',5-triiodothyronine (T3) and 3,3',5'-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs.

Authors:  E P Krenning; R Docter; B Bernard; T Visser; G Hennemann
Journal:  FEBS Lett       Date:  1982-04-19       Impact factor: 4.124

8.  Grades of hypothyroidism.

Authors:  D C Evered; B J Ormston; P A Smith; R Hall; T Bird
Journal:  Br Med J       Date:  1973-03-17

9.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.

Authors:  S Melmed; K Nademanee; A W Reed; J A Hendrickson; B N Singh; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

10.  [Amiodarone and the thyroid gland].

Authors:  M Stäubli; P Bischof; C Wimpfheimer; H Studer
Journal:  Schweiz Med Wochenschr       Date:  1981-10-24
View more
  10 in total

1.  Models for the binding of amiodarone to the thyroid hormone receptor.

Authors:  D K Chalmers; S L Munro; M N Iskander; D J Craik
Journal:  J Comput Aided Mol Des       Date:  1992-02       Impact factor: 3.686

Review 2.  Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling.

Authors:  Balázs Gereben; Ann Marie Zavacki; Scott Ribich; Brian W Kim; Stephen A Huang; Warner S Simonides; Anikó Zeöld; Antonio C Bianco
Journal:  Endocr Rev       Date:  2008-09-24       Impact factor: 19.871

3.  Brain abscess presenting as an intracranial gas shadow.

Authors:  K C Lee; J P McCann; D P Nicholls
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

4.  Amiodarone and thyroid autoimmunity in the United Kingdom.

Authors:  A P Weetman; S K Bhandal; J M Burrin; K Robinson; W McKenna
Journal:  BMJ       Date:  1988-07-02

5.  2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Authors:  Luigi Bartalena; Fausto Bogazzi; Luca Chiovato; Alicja Hubalewska-Dydejczyk; Thera P Links; Mark Vanderpump
Journal:  Eur Thyroid J       Date:  2018-02-14

6.  Management of amiodarone-related thyroid problems.

Authors:  Shashithej K Narayana; David R Woods; Christopher J Boos
Journal:  Ther Adv Endocrinol Metab       Date:  2011-06       Impact factor: 3.565

Review 7.  Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

Authors:  C M Newman; A Price; D W Davies; T A Gray; A P Weetman
Journal:  Heart       Date:  1998-02       Impact factor: 5.994

8.  Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis.

Authors:  Ankit N Mehta; Raphaelle D Vallera; Chad R Tate; Rebecca A Sager; Brian J Welch
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

9.  Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.

Authors:  Aaron N Snead; Motonori Miyakawa; Edwin S Tan; Thomas S Scanlan
Journal:  Bioorg Med Chem Lett       Date:  2008-08-09       Impact factor: 2.823

10.  Low dose amiodarone reduces tumor growth and angiogenesis.

Authors:  Eliana Steinberg; Arnon Fluksman; Chalom Zemmour; Katerina Tischenko; Adi Karsch-Bluman; Yifat Brill-Karniely; Amy E Birsner; Robert J D'Amato; Ofra Benny
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.